Cheryl A. Carlson

Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).

Zev A. Wainberg, Neil H. Segal, Dirk Jaeger et al. · Journal of Clinical Oncology · 2017 · 140 citations

Pharmacy, Oncology, Pharmacotherapy +15

Integrating Adenovirus–Adeno-Associated Virus Hybrid Vectors Devoid of All Viral Genes

André Lieber, Dirk S. Steinwaerder, Cheryl A. Carlson et al. · Journal of Virology · 1999 · 90 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +13

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer

Hanna K. Sanoff, Dominic H. Moon, Dominic T. Moore et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

DNA Replication of First-Generation Adenovirus Vectors in Tumor Cells

Dirk S. Steinwaerder, Cheryl A. Carlson, André Lieber · Human Gene Therapy · 2000 · 65 citations

Life Sciences, Molecular Biology, Oncology +15

A High-Capacity, Capsid-Modified Hybrid Adenovirus/Adeno-Associated Virus Vector for Stable Transduction of Human Hematopoietic Cells

Dmitry M. Shayakhmetov, Cheryl A. Carlson, Hartmut Stecher et al. · Journal of Virology · 2002 · 60 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +15